Abbott has withdrawn its first-generation fully absorbable vascular scaffold , Absorb GT1 Bioresorbable Vascular Scaffold System (BVS) from the global...
Abbott initiates ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the Absorb bioresorbable vascular scaffold for...
Abbott has announced that Absorb, the world's first drug eluting bioresorbable vascular scaffold (BVS), is now widely available across Europe...
The FDA has approved the Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), from Abbott Vascular, the first fully absorbable stent...
Abbott announced the start of the ABSORB IV clinical trial which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS)...
New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process following the implantation of DREAMS 3G, Biotronik’s third-generation resorbable magnesium scaffold (RMS).
Biotronik announced that the Magmaris bioresorbable scaffold has received CE mark approval. The first clinically proven magnesium scaffold, Magmaris grants...
Three-year results from 101 patients treated with the Absorb Vascular Scaffold (bioresorbable everolimus eluting stent system), from Abbott, in the...
REVA Medical, Inc. a leader in bioresorbable polymer technologies for vascular applications, announced CE Mark of the 2.5 millimeter diameter...
Positive long-term data are reported from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold...